<p>
<ol>
<li>Develop methodology to determine if antimicrobial-agent residues bound to fecal contents are microbiologically active.</li>
<li>Evaluate the use of current molecular biology, genomic, and proteomic technologies to determine the impact of antimicrobial-agent residues on the human-intestinal microbiota.</li>
<li>Determine the potential of the intestinal microbiota to metabolize antimicrobial residues.</li><ol></p>
Responsible Division: Microbiology